Indivior (INDV)

 

Latest News

Holding(s) in Company

RNS Number: 2109B Indivior PLC 08 January 2018 TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Indivior PLC 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer 2. Reason for the notification (plea...

Indivior to present at US healthcare conference

Indivior has confirmed that Shaun Thaxter, CEO, will present at the 36th Annual J.P. Morgan Healthcare Conference in Sa...

J.P. Morgan Healthcare Conference

RNS Number: 8852A Indivior PLC 04 January 2018 Indivior's Shaun Thaxter to Present at the 36 th Annual J.P. Morgan Healthcare Conference on January 11 th Slough, UK, and Richmond, VA, 4th January 2018 - Indivior PLC (LON: INDV) today announced that Shaun Thaxter, CEO, will present at the 36 th Annual J.P. Morgan Healthcare Conference on January 11t...

Indivior and Addex in strategic collaboration

Indivior UK has entered into a strategic collaboration with Addex Pharma, a wholly-owned subsidiary of Addex Therapeu...

All News

DateHeadlineSource
08-01-18Holding(s) in CompanyRNS
04-01-18Indivior to present at US healthcare conferenceStockMarketWire
04-01-18J.P. Morgan Healthcare ConferenceRNS
03-01-18Indivior and Addex in strategic collaborationStockMarketWire
03-01-18Indivior and Addex Enter Strategic CollaborationRNS
19-12-17Indivior amends and extends debt facilitiesStockMarketWire
19-12-17Indivior amends and extends $534m debt facilitiesRNS
12-12-17 Indivior NDA for schizophrenia drug accepted by FDAStockMarketWire
12-12-17Indivior's RBP-7000 NDA Accepted by FDARNS
08-12-17Indivior to issue shares under LTIP StockMarketWire
08-12-17Additional ListingRNS
01-12-17OPEC oil production cut fails to lift FTSE StockMarketWire
01-12-17FTSE falls amid Corbyn 'threat' to banksStockMarketWire
01-12-17Indivior's Sublocade gets FDA approval StockMarketWire
01-12-17FDA Approves SUBLOCADE (TM)RNS
23-11-17Holding(s) in CompanyRNS
10-11-17Block listing Interim ReviewRNS
09-11-17Broker Forecast - Jefferies International issues a broker note on Indivior PlcStockMarketWire
08-11-1710 top shares with the magic formula Interactive Investor
08-11-17Broker Forecast - Citigroup issues a broker note on Indivior PlcStockMarketWire
06-11-17Indivior CEO to present at London healthcare conference StockMarketWire
06-11-17Jefferies London Healthcare ConferenceRNS
02-11-17Indivior reconfirms FY guidanceStockMarketWire
02-11-17Board Committee ChangesRNS
02-11-17Holding(s) in CompanyRNS
02-11-173rd Quarter ResultsRNS
01-11-17Mining rally fails to offset weaker utility stocksStockMarketWire
01-11-17Broker Forecast - Numis issues a broker note on Indivior PlcStockMarketWire
01-11-17Upbeat Chinese manufacturing data drives mining rallyStockMarketWire
01-11-17FDA advisory committees approve Indivior's OUD treatment StockMarketWire
01-11-17FDA Advisory Committees Vote to Approve RBP-6000RNS
26-10-17Broker Forecast - Citigroup issues a broker note on Indivior PlcStockMarketWire
20-10-17Broker Forecast - Numis issues a broker note on Indivior PlcStockMarketWire
10-10-17Indivior schedules Q3 results StockMarketWire
10-10-17Notice of ResultsRNS
09-10-17Holding(s) in CompanyRNS
03-10-17FDA Posts Advisory Committee Notice for RBP-6000RNS
02-10-17Miners help to drive FTSE 100 higherStockMarketWire
02-10-17FTSE rises as miners, housebuilders and airlines gain momentumStockMarketWire
02-10-17RBP-7000 - Submission of NDA to U.S. FDARNS

RSS feeds

  • Editorial news feed for LSE:INDV Editorial
  • Regulatory news feed for LSE:INDV Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account